China Universal Asset Management Co., Ltd. Fate Therapeutics Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 22,845 shares of FATE stock, worth $34,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,845
Previous 24,150
5.4%
Holding current value
$34,724
Previous $39,000
53.85%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding FATE
# of Institutions
144Shares Held
97MCall Options Held
56.7KPut Options Held
5.4K-
Redmile Group, LLC San Francisco, CA12.9MShares$19.6 Million1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$15.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$15.4 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY7.79MShares$11.8 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.29MShares$6.52 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $147M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...